Cara Therapeutics
CARA
#10367
Rank
C$11.2 M
Marketcap
C$7.35
Share price
-2.56%
Change (1 day)
1,824.02%
Change (1 year)

Revenue for Cara Therapeutics (CARA)

Revenue in 2024 (TTM): C$9.78 Million

According to Cara Therapeutics 's latest financial reports the company's current revenue (TTM ) is C$9.85 Million. a decrease over the revenue in the year 2023 that were of C$27.81 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cara Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 C$10.24 M-63.17%
2023 C$27.81 M-51.05%
2022 C$56.81 M93.58%
2021 C$29.34 M-82.96%
2020 C$0.17 B563.16%
2019 C$25.97 M41.56%
2018 C$18.34 M1501.9%
2017 C$1.14 M891.04%
2016 C$0.11 M-97.81%
2015 C$5.27 M43.09%
2014 C$3.68 M-71.05%
2013 C$12.73 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Trevena
TRVN
C$0.75 M-92.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
C$0.13 B 1,306.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
C$0.10 B 955.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
C$0.89 M-90.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$86.73 B 879,625.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$127.30 B 1,291,044.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$0.15 B 1,520.62%๐Ÿ‡บ๐Ÿ‡ธ USA